0001415889-24-015683.txt : 20240605 0001415889-24-015683.hdr.sgml : 20240605 20240605193850 ACCESSION NUMBER: 0001415889-24-015683 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lin Xichen CENTRAL INDEX KEY: 0001962926 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41608 FILM NUMBER: 241023527 MAIL ADDRESS: STREET 1: C/O STRUCTURE THERAPEUTICS INC. STREET 2: 611 GATEWAY BLVD, SUITE 223 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Structure Therapeutics Inc. CENTRAL INDEX KEY: 0001888886 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981480821 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD SUITE 223 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (628) 229-9277 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD SUITE 223 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ShouTi Inc. DATE OF NAME CHANGE: 20211019 4 1 form4-06052024_110646.xml X0508 4 2024-06-03 0001888886 Structure Therapeutics Inc. GPCR 0001962926 Lin Xichen C/O STRUCTURE THERAPEUTICS INC. 601 GATEWAY BLVD., SUITE 900 SOUTH SAN FRANCISCO CA 94080 false true false false CHIEF SCIENTIFIC OFFICER 1 Ordinary Shares 2024-06-03 4 M 0 106200 0.34 A 191907 D Ordinary Shares 2024-06-03 4 C 0 106200 0 D 85707 D Share Option (right to buy) 0.34 2024-06-03 4 M 0 106200 0 D 2029-09-10 Ordinary Shares 106200 213800 D American Depositary Shares 2024-06-03 4 C 0 35400 0 A Ordinary Shares 106200 35400 D American Depositary Shares 2024-06-03 4 S 0 17700 45 D Ordinary Shares 53100 17700 D American Depositary Shares 2024-06-03 4 S 0 17700 50.004 D Ordinary Shares 53100 0 D The Ordinary Shares were converted into American Depositary Shares as reported in Table II above. 1/4 of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 106,200 Ordinary Shares. Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. 106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares. The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023. The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. /s/ Jun Yoon, Attorney-in-Fact 2024-06-05